T. Rowe Price Associates
AMGN icon

T. Rowe Price Associates’s Amgen AMGN Stock Holding History

T. Rowe Price Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$657M Buy
1,867,189
+823,432
+79% +$294M 0.08% 206
2025
Q4 		$342M Sell
1,043,757
-11,823
-1% -$3.75M 0.04% 323
2025
Q3 		$298M Sell
1,055,580
-86,945
-8% -$25.2M 0.03% 363
2025
Q2 		$319M Sell
1,142,525
-895,054
-44% -$254M 0.04% 339
2025
Q1 		$635M Sell
2,037,579
-605,538
-23% -$179M 0.08% 238
2024
Q4 		$689M Sell
2,643,117
-1,903,289
-42% -$565M 0.08% 219
2024
Q3 		$1.46B Buy
4,546,406
+24,792
+0.5% +$8.11M 0.17% 120
2024
Q2 		$1.41B Buy
4,521,614
+1,384,123
+44% +$407M 0.17% 116
2024
Q1 		$892M Sell
3,137,491
-3,427,219
-52% -$1B 0.11% 178
2023
Q4 		$1.89B Buy
6,564,710
+243,720
+4% +$66.4M 0.25% 83
2023
Q3 		$1.7B Buy
6,320,990
+1,480,001
+31% +$369M 0.25% 84
2023
Q2 		$1.07B Buy
4,840,989
+1,018,577
+27% +$236M 0.15% 147
2023
Q1 		$924M Buy
3,822,412
+872,399
+30% +$214M 0.14% 158
2022
Q4 		$775M Buy
2,950,013
+1,806,456
+158% +$484M 0.12% 167
2022
Q3 		$258M Sell
1,143,557
-730,736
-39% -$177M 0.04% 319
2022
Q2 		$456M Sell
1,874,293
-788,648
-30% -$193M 0.06% 310
2022
Q1 		$644M Sell
2,662,941
-5,595
-0.2% -$1.29M 0.06% 286
2021
Q4 		$600M Buy
2,668,536
+47,146
+2% +$9.95M 0.05% 323
2021
Q3 		$557M Sell
2,621,390
-99,938
-4% -$23M 0.05% 330
2021
Q2 		$663M Sell
2,721,328
-135,011
-5% -$33.2M 0.06% 298
2021
Q1 		$711M Sell
2,856,339
-204,010
-7% -$48.7M 0.07% 282
2020
Q4 		$704M Sell
3,060,349
-525,306
-15% -$121M 0.07% 269
2020
Q3 		$911M Buy
3,585,655
+18,576
+0.5% +$4.6M 0.11% 205
2020
Q2 		$841M Sell
3,567,079
-867,966
-20% -$198M 0.11% 198
2020
Q1 		$899M Buy
4,435,045
+507,220
+13% +$111M 0.14% 152
2019
Q4 		$947M Buy
3,927,825
+14,039
+0.4% +$3.09M 0.12% 180
2019
Q3 		$757M Buy
3,913,786
+1,133,325
+41% +$218M 0.11% 207
2019
Q2 		$512M Buy
2,780,461
+239,576
+9% +$42.9M 0.07% 276
2019
Q1 		$483M Buy
2,540,885
+150,305
+6% +$28.7M 0.07% 278
2018
Q4 		$465M Buy
2,390,580
+126,143
+6% +$24.6M 0.08% 245
2018
Q3 		$469M Sell
2,264,437
-316,483
-12% -$62.4M 0.07% 283
2018
Q2 		$476M Sell
2,580,920
-54,504
-2% -$9.64M 0.07% 261
2018
Q1 		$449M Sell
2,635,424
-47,843
-2% -$8.78M 0.07% 276
2017
Q4 		$467M Sell
2,683,267
-110,647
-4% -$19.6M 0.08% 270
2017
Q3 		$521M Sell
2,793,914
-187,784
-6% -$33.3M 0.09% 246
2017
Q2 		$514M Sell
2,981,698
-278,170
-9% -$45.2M 0.09% 242
2017
Q1 		$535M Sell
3,259,868
-200,555
-6% -$33.3M 0.1% 226
2016
Q4 		$506M Buy
3,460,423
+482,298
+16% +$72.6M 0.1% 232
2016
Q3 		$497M Buy
2,978,125
+256,691
+9% +$43.4M 0.1% 232
2016
Q2 		$414M Sell
2,721,434
-102,804
-4% -$16M 0.09% 249
2016
Q1 		$423M Sell
2,824,238
-317,947
-10% -$47.2M 0.09% 247
2015
Q4 		$510M Sell
3,142,185
-72,156
-2% -$11.3M 0.11% 207
2015
Q3 		$445M Sell
3,214,341
-1,141,646
-26% -$180M 0.1% 227
2015
Q2 		$669M Sell
4,355,987
-104,433
-2% -$16.7M 0.14% 169
2015
Q1 		$713M Sell
4,460,420
-157,461
-3% -$24.8M 0.15% 170
2014
Q4 		$736M Sell
4,617,881
-178,988
-4% -$27.9M 0.16% 171
2014
Q3 		$674M Sell
4,796,869
-192,270
-4% -$25.1M 0.15% 169
2014
Q2 		$591M Sell
4,989,139
-62,464
-1% -$7.23M 0.13% 197
2014
Q1 		$623M Buy
5,051,603
+42,949
+0.9% +$5.21M 0.14% 186
2013
Q4 		$572M Sell
5,008,654
-2,173,500
-30% -$247M 0.13% 189
2013
Q3 		$804M Buy
7,182,154
+786,675
+12% +$85.3M 0.2% 130
2013
Q2 		$631M Buy
+6,395,479
New +$664M 0.17% 153

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates's AMGN Position: Q1 2026 in Review

T. Rowe Price Associates increased its Amgen (AMGN) stake by 79% in Q1 2026, buying an estimated $294M and bringing the position to 1,867,189 shares worth $657M. The position accounts for 0.08% of the portfolio, ranked #206.

T. Rowe Price Associates first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.89B in Q4 2023. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • T. Rowe Price Associates held 1,867,189 shares of Amgen worth $657M as of Q1 2026.
  • T. Rowe Price Associates bought 823,432 Amgen shares in Q1 2026, an estimated $294M.
  • Amgen made up 0.08% of T. Rowe Price Associates's portfolio in Q1 2026, its #206 holding.
  • T. Rowe Price Associates first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Amgen position peaked at $1.89B in Q4 2023.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.